A $1.5 million gift to the University of Pennsylvania has established the Barbara and Edward Netter Associate Professorship in Cancer Gene Therapy at the Abramson Cancer Center. Bruce Levine, PhD, a faculty member in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and the director of the Clinical Cell and Vaccine Production Facility, has been appointed to the Barbara and Edward Netter Associate Professor in Cancer Gene Therapy.
Read more
Department faculty members Don Siegel, PhD, MD, and David B. Roth, MD, PhD, were speakers at the Inaugural Annual Blood Center Symposium at the Penn-CHOP Blood Center for Patient Care and Discovery on Tuesday, October 8, 2013. Their symposium lectures were on the evolving roles of transfusion medicine and cellular engineering for hematologic disorders and on personalized medicine for patients with blood disorders, respectively.
Read more
Researchers from the Perelman School of Medicine at the University of Pennsylvania demonstrate for the first time that the immune system influences the skin microbiome. A new study found that the skin microbiome–a collection of microorganisms inhabiting the human body–is governed, at least in part, by an ancient branch of the immune system called complement. In turn, it appears microbes on the skin tweak the complement system, as well as immune surveillance of the skin.
Read more
Recently, Penn's Center for Neurodegenerative Disease Research was one of the stops during an informational tour conducted for Philip Rubin, Principal Assistant Director for Science at The White House Office of Science and Technology Policy (OSTP), to demonstrate the breadth of brain-related research at Penn Medicine.
Read more
The award recognizes Dr. Kricka's efforts to document and describe the origins, development, and impact of clinical chemistry on the practice of medicine.
Read more
An elaborate and detailed article in the August edition of Philadelphia Magazine offers a dramatic narrative for the development of the CART19 gene therapy, the breakthrough Penn Medicine treatment that uses engineered versions of patients' own immune cells to fight their cancers.
Read more
The American Association for Clinical Chemistry (AACC) announced that Leslie M. Shaw, PhD, Professor of Pathology and Laboratory Medicine, is the recipient of the Association’s 2013 Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine. The Award, established in 1952 and until 2007 known “Outstanding Contributions to Clinical Chemistry Award,” is bestowed annually. It is considered the premier award of the Association and is granted as a "lifetime achievement" award for contributions to the field of clinical chemistry.
Read more
The Pew Charitable Trusts announced today that Claudio Giraudo, PhD, Assistant Professor in the Department of Pathology and Laboratory Medicine based in the Children's Hospital of Philadelphia, is one of this year's twenty-two Pew Scholars in the Biomedical Sciences. The Pew scholarships provide flexible funding to early-career scientists researching the basis of perplexing health problems—including diabetes, autism, Parkinson’s disease, and cancer.
Read more
Investigators in the Gene Therapy Program, Department of Pathology and Laboratory Medicine, directed by James M. Wilson, MD, PhD, have demonstrated that a single dose of an adeno-associated virus (AAV) expressing a broadly neutralizing flu antibody into the nasal passages of mice and ferrets gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus. These strains were isolated from samples associated from historic human pandemics – one from the infamous 1918 flu pandemic and another from 2009.
Read more
Peter Nowell, MD, is one of three recipients of this year's prestigious Albany Medical Center Prize in Medicine and Biomedical Research, to be officially awarded May 17. Dr. Nowell shares the award with Dr. Janet Rowley of the University of Chicago and Dr. Brian Druker of the Oregon Health and Science University. The $500,000 award, given to those who have altered the course of medical research, is one of the largest prizes in medicine and science in the United States.
Read more
Pages
